The Global Drug Facility: A unique, holistic and pioneering approach to drug procurement and management

Bulletin of the World Health Organization

Volumn 85, Issue 5, 2007, Pages

  Matiru, Robert ^a   Ryan, Timothy ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

DISEASE CONTROL; DISEASE INCIDENCE; DISEASE PREVALENCE; DISEASE TREATMENT; DRUG; EQUITY; MORTALITY; PLANNING PROCESS; PUBLIC ACCESS; TUBERCULOSIS;

COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC KIT; DRUG MANUFACTURE; DRUG QUALITY; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MORBIDITY; MORTALITY; PREVALENCE; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SHORT COURSE THERAPY; TREATMENT PLANNING; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHILD; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FINANCIAL MANAGEMENT; HEALTHY PEOPLE PROGRAMS; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; MODELS, ORGANIZATIONAL; PREVALENCE; QUALITY ASSURANCE, HEALTH CARE; REAGENT KITS, DIAGNOSTIC; TUBERCULOSIS; WORLD HEALTH;

EID: 34248163357     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.06.035402     Document Type: Review

References (11)

1. Global TB drug facility: prospectus. Geneva: WHO; 2001 (WHO/CDS/STB/ 2001.10a).
2. The Stop TB Strategy. Geneva: WHO; 2006 (WHO/HTM/TB/2006.368).
3. Kumaresan J, Smith I, Arnold V, Evans P. The Global TB Drug Facility: innovative global procurement. Int J Tuberc Lung Dis 2004;8:130-8.
4. Management Sciences for Health. International drug price indicator guide. Arlington: MSH; 2002. Available at: http://erc.msh.org/dmpguide/
5. ISO 9000 and ISO 14000 in brief. Geneva: International Organization for Standardization. Available at: http://www.iso.org/iso/en/ iso9000-14000/understand/inbrief.html
6. Arnold V, Smith I. The Global Drug Facility: a revolution in tuberculosis control. In: Raviglione MC, ed. Reichman and Hershfield's tuberculosis: a comprehensive international approach. 3rd ed. New York: Informa Healthcare; 2006.
7. Sustaining the gains: national self-sufficiency for anti-TB drug access. A Global Drug Facility strategy. Geneva: WHO; 2005 (WHO/HTM/STB/2005.34).
8. Stop TB Partnership Global Drug Facility. Progress reports, 2001-2005. Available at: http://www.stoptb.org/gdf/whatis/documents.asp
9. Counterfeit medicines. Geneva: WHO; 2006. Available at: http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index.html
10. Stop TB Partnership. Retooling Task Force. Available at: http://www.stoptb.org/retooling
11. GAVI Alliance. Financing task force compendium: financial sustainability planning. Available at: http://www.gavialliance.org/ Governance/formertaskforces/Financing_Task_Force/ financial_sustainability_planning.php